282 related articles for article (PubMed ID: 26193703)
21. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
Iguchi A; Kazama JJ; Yamamoto S; Yoshita K; Watanabe Y; Iino N; Narita I
Nephron; 2015; 131(3):161-6. PubMed ID: 26551233
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
[TBL] [Abstract][Full Text] [Related]
23. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor 23 in untreated nephrotic syndrome.
Yadav AK; Ramachandran R; Aggarwal A; Kumar V; Gupta KL; Jha V
Nephrology (Carlton); 2018 Apr; 23(4):362-365. PubMed ID: 28087977
[TBL] [Abstract][Full Text] [Related]
25. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
26. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
[TBL] [Abstract][Full Text] [Related]
27. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
[TBL] [Abstract][Full Text] [Related]
28. Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.
Haring R; Enserro D; Xanthakis V; Mitchell GF; Benjamin EJ; Hamburg NM; Sullivan L; Nauck M; Wallaschofski H; Vasan RS
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27385427
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
[TBL] [Abstract][Full Text] [Related]
30. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.
Vervloet MG; van Ittersum FJ; Büttler RM; Heijboer AC; Blankenstein MA; ter Wee PM
Clin J Am Soc Nephrol; 2011 Feb; 6(2):383-9. PubMed ID: 21030580
[TBL] [Abstract][Full Text] [Related]
31. Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients.
Baia LC; Van den Berg E; Vervloet MG; Heilberg IP; Navis G; Bakker SJ; Geleijnse JM; Kromhout D; Soedamah-Muthu SS; De Borst MH;
Nutr Metab Cardiovasc Dis; 2014 Dec; 24(12):1310-6. PubMed ID: 25063539
[TBL] [Abstract][Full Text] [Related]
32. PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.
Ginsberg C; Craven TE; Chonchol MB; Cheung AK; Sarnak MJ; Ambrosius WT; Killeen AA; Raphael KL; Bhatt UY; Chen J; Chertow GM; Freedman BI; Oparil S; Papademetriou V; Wall BM; Wright CB; Ix JH; Shlipak MG;
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1816-1824. PubMed ID: 30425104
[TBL] [Abstract][Full Text] [Related]
33. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
[TBL] [Abstract][Full Text] [Related]
34. Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism.
Kuczera P; Adamczak M; Wiecek A
Clin Endocrinol (Oxf); 2014 Apr; 80(4):607-12. PubMed ID: 24111496
[TBL] [Abstract][Full Text] [Related]
35. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease.
Xue C; Yang B; Zhou C; Dai B; Liu Y; Mao Z; Yu S; Mei C
Am J Nephrol; 2017; 45(2):149-159. PubMed ID: 28006765
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Wright CB; Shah NH; Mendez AJ; DeRosa JT; Yoshita M; Elkind MS; Sacco RL; DeCarli C; Rundek T; Silverberg S; Dong C; Wolf M
Stroke; 2016 Apr; 47(4):923-8. PubMed ID: 26956260
[TBL] [Abstract][Full Text] [Related]
38. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
[TBL] [Abstract][Full Text] [Related]
39. Intake of phytosterols from natural sources and risk of cardiovascular disease in the European Prospective Investigation into Cancer and Nutrition-the Netherlands (EPIC-NL) population.
Ras RT; van der Schouw YT; Trautwein EA; Sioen I; Dalmeijer GW; Zock PL; Beulens JW
Eur J Prev Cardiol; 2015 Aug; 22(8):1067-75. PubMed ID: 25305273
[TBL] [Abstract][Full Text] [Related]
40. Consequences of a high phosphorus intake on mineral metabolism and bone remodeling in dependence of calcium intake in healthy subjects - a randomized placebo-controlled human intervention study.
Trautvetter U; Jahreis G; Kiehntopf M; Glei M
Nutr J; 2016 Jan; 15():7. PubMed ID: 26786148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
